Fig. 4. Pattern and average tracking period days of acquiring anti-myco-bacterial resistance in R groups (cases of resistance to rifampin anti-tuber-culosis drug at the time of initial referral).
Abbreviations: See Figure 2.

Korean J Clin Lab Sci 2022;54:125-32 https://doi.org/10.15324/kjcls.2022.54.2.125

© 2022 Korean J Clin Lab Sci